Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Molecular Profiling of Advanced Biliary Tract Cancers (BTC) for Better Treatment Selection: A Prospective Study (COMPASS B)

NCT03419247 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03419247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03419247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Molecular Profiling of Advanced Biliary Tract Cancers (BTC) for Better Treatment Selection: A Prospective Study (COMPASS B)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Withdrawn
Start date
January 1, 2020
Completion date
January 2, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer